Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth quarter 2024 investor letter. A ...

Berenberg Bank analyst Sebastian Bray maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €22.00. The ...

Bayer AG’s stock slumped on Tuesday as the German giant issued a profit warning on agricultural demand. Germany-listed shares ...

Bayer argues PCB levels were safe, blames school for ignoring warnings Previous trials resulted in over $1.5 billion in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Bayer's most recent financial performance has ... Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate ...

According to Yahoo!Finance, Bayer’s market cap has fallen more than 44% this year. The stock price hit a 20-year low last November. Slashing management jobs, in Bayer’s case, didn’t yield ...

Kepler Capital analyst Christian Faitz maintained a Hold rating on Bayer (0P6S – Research Report) on January 21 and set a price target of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer Australian judge dismisses class action lawsuit against Bayer for Roundup causing ...

Find the latest Bayer AG N BAYN.DE analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study Regeneron's EYLEA HD met key goals in the Phase 3 QUASAR trial for ...